Edinburgh Partners LTD Maintains Stake in Celgene Corp (CELG)

Marco Green
April 16, 2018

The institutional investor owned 34,600 shares of the biopharmaceutical company's stock after buying an additional 1,299 shares during the quarter. When we divide the last trade volume by the 3-month average volume, we found out a relative volume of 0.52. 4135109 shares traded on hands in the recent trading session. CELG underperformed the S&P500 by 42.83%.

Zevenbergen Capital Investments Llc increased its stake in Celgene Corporation (CELG) by 8.7% based on its latest 2017Q4 regulatory filing with the SEC. In the last quarter, insiders have sold 41,120 shares of company stock valued at $3,879,509. The institutional investor held 5.11M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $533.61 million, down from 5.23 million at the end of the previous reported quarter. It closed at $0.04 lastly. Oracle Corporation (NYSE:ORCL) has risen 1.20% since April 16, 2017 and is uptrending. It has outperformed by 15.49% the S&P500.

Among 55 analysts covering Facebook (NASDAQ:FB), 50 have Buy rating, 2 Sell and 3 Hold. Therefore 25% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. Wall Street is only getting more bullish on the stock, with 16 of analysts who cover CELG having a buy-equivalent rating. The stock was bought at an average cost of $91.90 per share, with a total value of $299,594.00. JMP Securities downgraded the stock to "Hold" rating in Friday, October 27 report. Barclays Capital maintained Celgene Corporation (NASDAQ:CELG) rating on Friday, October 20. The stock of Celgene Corporation (NASDAQ:CELG) earned "Overweight" rating by Atlantic Securities on Friday, December 8. The firm has "Buy" rating by Citigroup given on Tuesday, February 13. The stock has "Buy" rating by Suntrust Robinson on Thursday, April 28. The rating was maintained by Brean Capital on Wednesday, July 27 with "Buy". As per Monday, November 23, the company rating was maintained by Credit Suisse. As per Wednesday, June 14, the company rating was maintained by Oppenheimer.

This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell. On Monday, January 8 Stifel Nicolaus maintained Celgene Corporation (NASDAQ:CELG) rating. (NYSE:A) has "Overweight" rating given on Thursday, February 15 by JP Morgan.

During 2017 Q4 the big money sentiment decreased to 0.83. Its up 0.09, from 1.02 in 2017Q3. It dropped, as 156 investors sold CELG shares while 478 reduced holdings. The active investment managers in our database now have: 561.38 million shares, down from 603.99 million shares in 2017Q3. Fiduciary Trust reported 26,054 shares. Regentatlantic Cap Lc has invested 0.18% of its portfolio in Celgene Corporation (NASDAQ:CELG). Janney Cap Mngmt Ltd Liability Co has 0.02% invested in Celgene Corporation (NASDAQ:CELG). Sfe Invest Counsel accumulated 52,257 shares. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 16, 2017 and is downtrending.

Birchview Capital Lp holds 45.52% of its portfolio in Celgene Corporation for 744,051 shares. Peak6 Invests Lp holds 0.11% or 223,105 shares. Cibc World invested in 0% or 17,863 shares. 57,310 were reported by Comm Of Vermont.

In other Celgene news, insider Mark J. Alles bought 3,260 shares of Celgene stock in a transaction dated Thursday, February 8th. MARIO ERNEST also sold $1.26 million worth of Celgene Corporation (NASDAQ:CELG) shs. Edgewood Management LLC now owns 10,556,896 shares of the biopharmaceutical company's stock worth $1,539,407,000 after purchasing an additional 98,943 shares during the period. The stock of Celgene Corporation (NASDAQ:CELG) earned "Outperform" rating by BMO Capital Markets on Friday, November 17. One analyst has rated the stock with a sell rating, four have assigned a hold rating, twenty-four have given a buy rating and one has issued a strong buy rating to the stock. Therefore 88% are positive. Brown & Brown had 52 analyst reports since August 24, 2015 according to SRatingsIntel. The stock of Amazon.com, Inc. On Tuesday, February 13 the stock rating was upgraded by Barclays Capital to "Buy". (NYSE:FLT) rating on Friday, August 5.

Celgene declared that its board has initiated a share buyback program on Wednesday, February 14th that authorizes the company to repurchase $5.00 billion in shares. Monness Crespi & Hardt maintained FleetCor Technologies, Inc. (NASDAQ:AMZN) on Friday, July 29 with "Buy" rating. This means that the higher growth rate of MTDR implies a greater potential for capital appreciation over the years. Virtus Advisers stated it has 0.04% of its portfolio in Celgene Corporation (NASDAQ:CELG). Linscomb & Williams Inc. now owns 3,813 shares of the biopharmaceutical company's stock worth $495,000 after purchasing an additional 36 shares during the last quarter.

Shares of CELG stock opened at $89.40 on Monday. On Thursday, January 18 the insider McMullen Michael R. sold $1.58M. Also, Director James J. Loughlin sold 9,250 shares of the company's stock in a transaction on Monday, March 12th. Kaltenbach Patrick sold 4,000 shares worth $269,113.

Investors sentiment decreased to 0.83 in Q4 2017.

Since January 26, 2018, it had 1 insider purchase, and 0 sales for $43,446 activity. Finally, Family Management Corp raised its stake in shares of Celgene by 39.4% in the second quarter. 151 funds opened positions while 383 raised stakes. Sumitomo Mitsui Asset Management Limited stated it has 0.01% of its portfolio in Medley Capital Corporation (NYSE:MCC). (NASDAQ:AMZN) or 2,417 shares. (NYSE:FLT). Criterion Mngmt Ltd Limited Liability Company accumulated 4.61% or 398,225 shares. Moreover, Nj State Employees Deferred Compensation Plan has 1.62% invested in Amazon.com, Inc. First Natl Tru, a Pennsylvania-based fund reported 10,638 shares. (NASDAQ:AAPL) for 51,393 shares. Td Cap Mgmt Lc owns 34 shares for 0.01% of their portfolio. Bluemountain Capital Ltd invested in 140,323 shares or 0.3% of the stock. (NASDAQ:AMZN). Bourgeon Mgmt reported 540 shares or 0.35% of all its holdings. Allen Operations Limited Liability Co reported 0.22% of its portfolio in Facebook, Inc.

Other reports by Click Lancashire

Discuss This Article